Trials / Completed
CompletedNCT05123950
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Patients in Europe
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 304 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to collect real-world data that describes treatment patterns and clinical outcomes in participants with first line recurrent/metastatic squamous cell carcinoma of the head \& neck (1L R/M SCCHN).
Conditions
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2021-03-19
- Completion
- 2021-03-19
- First posted
- 2021-11-17
- Last updated
- 2021-11-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05123950. Inclusion in this directory is not an endorsement.